Cervical cancer is the fourth most prevalent cancer in women worldwide, with an estimated 580 000 new cases in 2018. Most fatalities - approximately 90% - are concentrated in low- and middle-income countries, particularly in regions with high HIV prevalence. This can be attributed largely to the scarcity of preventive and screening measures, as well as limited treatment options.

Cervical cancer, curable when detected early, poses a challenge in developing countries like Malawi, where women often seek treatment only in...